The Cancer Biology Division’s principal investigators study the factors and processes that affect the development, proliferation and spread of cancer. These scientists use proteomic and genomic screening, advanced mouse models and studies of human tissues to advance knowledge in radiation biology, genomics, molecular targeting and immunology. They work with clinical partners to design and execute clinical trials aimed at finding better ways to prevent, diagnose and treat cancer. The division has a distinguished history of translational research that has helped advance the treatment of head and neck, lung, breast, skin and prostate cancers. It’s a rich environment that offers exceptional educational opportunities for undergraduates, graduates and postdoctoral fellows.